Back to top
more

Moderna (MRNA)

(Real Time Quote from BATS)

$57.46 USD

57.46
872,799

+0.15 (0.26%)

Updated Oct 16, 2024 11:00 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value B Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (91 out of 250)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Sweta Killa headshot

Evergreen Tree of ETFs to Lighten Your Christmas

The Christmas tree of top-ranked ETFs to brighten 2021 is now ready for investors. May it spread cheer!

Radhika Saraogi headshot

5 Bank Stocks Set to Rebound With Vaccine-Driven Economic Recovery

Improving lending scenarios and restoration of normal activities in 2021, with the help of coronavirus vaccines rollout, will likely help banks like JPMorgan (JPM), Bank of Hawaii (BOH), Bank OZK (OZK), UMB Financial (UMBF) and Synovus (SNV) witness a rebound.

3 Airlines Stocks to Gain as the Economy Looks to Fully Reopen

Rollout of the vaccine along with an expected fiscal stimulus is sure to boost the airlines industry, making it prudent to watch out for names like Mesa Air Group (MESA) and Spirit Airlines (SAVE).

Mark Vickery headshot

Small-Caps at Record Highs Ahead of Christmas

The small-cap Russell 2000 index has hit another closing record high today -- the 13th time this has occurred this year.

Sweta Killa headshot

5 Best-Performing Leveraged ETFs of Fourth Quarter

We highlight some leveraged ETFs that gained more than 85% over the past three months.

Biotech Stock Roundup: PFE/BNTX Vaccine Authorized in Europe, Updates From AMGN, & More

Coronavirus vaccine updates from Moderna (MRNA) and Pfizer (PFE)/BioNTech (BNTX) continue to take centerstage in the biotech sector.

Vertex (VRTX) Inks Deal with Skyhawk for Serious Diseases

Vertex (VRTX) signs a licensing agreement with privately held company Skyhawk Therapeutics to discover novel small molecules that modulate RNA splicing for treating serious diseases.

Urmimala Biswas headshot

4 MedTech Stocks Up More Than 100% in 2020 With Room to Run

We discuss four MedTech stocks, CDNA, FLGT, OMI and QDEL that more than doubled in 2020, and are poised to maintain market beating momentum in 2021 on strong fundamentals.

Indrajit Bandyopadhyay headshot

How Effective Will Vaccines be Against New Coronavirus Strain?

Pfizer (PFE) and Moderna (MRNA), the companies whose coronavirus vaccines have been approved for emergency use, are evaluating their vaccines against the fast-spreading new strain of coronavirus found in the United Kingdom.

Sweta Killa headshot

5 High Beta & Momentum ETFs to Tap the Santa Rally

These ETFs are expected to outperform in the seven-day period and are intriguing choices for a short spell.

Mrithunjoy Kaushik headshot

4 Restaurant Stocks to Play a Likely Turnaround in 2021

Although the restaurant industry is grappling with the coronavirus outbreak, restaurant stocks like JACK, RUTH, FAT and STKS have impressive 2021 earnings growth projections.

Sanghamitra Saha headshot

Forget Sector Rotation: Tech ETFs to Rule in Christmas Week

News of new virus strain in the UK will likely keep the market subdued this week and brighten the appeal for tech ETFs.

Pfizer/BioNTech COVID-19 Vaccine Gets Authorization in Europe

Pfizer (PFE)/BioNTech's (BNTX) COVID-19 vaccine candidate is the first COVID-19 vaccine to be granted conditional authorization in Europe.

David Borun headshot

More New Highs for Stocks With Fiscal Stimulus Looking Imminent

Even with rising Covid-19 cases, a deal in Washington and the vaccine rollout keep investors in a buying mood.

Sweta Killa headshot

5 Small-Cap ETFs Set to Explode on COVID-19 Vaccines

As the economy seems on track for strong growth, a small-cap rally is expected to strengthen in the New Year.

Christmas Week Begins With Pre-market Sell-off

Christmas Week Begins With Pre-market Sell-off

Mark Vickery headshot

Pre-Markets Down to Start Christmas Week

Though already off the lows we saw a couple hours before today's opening bell, the Dow is down 400 points, the S&P 500 -55 and the Nasdaq -140.

Moderna (MRNA) Gets FDA Emergency Use Nod for COVID-19 Vaccine

Moderna (MRNA) gets emergency use authorization for coronavirus vaccine, mRNA-1273, for use in adults in the United States.

    Ekta Bagri headshot

    5 Biotech Stocks That More Than Doubled This Year

    The biotech sector has been in focus through 2020 as companies like Moderna (MRNA) strive hard to develop a vaccine for COVID-19.

    4 Restaurant Stocks to Watch as Vaccine Rollout Begins

    Vaccine rollout should allow dine-in to resume in restaurants with online delivery expected to sustain, making it prudent to keep an eye on names like Brinker International (EAT) and McDonald's (MCD)

    Sweta Killa headshot

    Vaccines to Fuel Santa Claus Rally: 5 Stock Picks

    With only eight trading days left this year, markets are bracing for the so-called Santa Claus rally.

    Moderna's (MRNA) COVID-19 Vaccine Gets FDA Panel's Backing

    An FDA panel recommends granting approval for emergency use to Moderna's (MRNA) coronavirus vaccine candidate.

    J&J (JNJ) Coronavirus Vaccine Candidate Study Fully Enrolled

    Johnson & Johnson (JNJ) phase III study on its experimental COVID-19 single-dose vaccine candidate is now fully enrolled.

    Sanghamitra Saha headshot

    7 Nasdaq Stocks That Helped QQQ ETF Score Big in 2020

    Technology stocks and ETFs have been star performers this year and made the tech-heavy index Nasdaq a winner.

    FDA Approves Second COVID-19 Vaccine

    FDA Approves Second COVID-19 Vaccine.